WHO recommends two Ebola vaccine candidates for trials as Bundibugyo outbreak spreads in DRC and Uganda with no approved treatment yet.

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are…

Mentre l'epidemia di Ebola causata dal virus Bundibugyo continua a estendersi, l’OMS e le organizzazioni umanitarie avvertono che potrebbero servire

GENEVA: The World Health Organization said Thursday its advisory groups had recommended clinical trials for vaccines and treatments that could be useful against the Bundibugyo…

The WHO advisors also recommended evaluating combination therapy using a monoclonal antibody together with remdesivir.

The WHO has identified promising treatments and vaccines for the rare Ebola strain killing hundreds in the Democratic Republic of Congo, but none are ready yet.

Treatments should be used exclusively in trials to ensure safety and effectiveness, group says

Advisory groups convened by the World Health Organization have considered promising candidates for prioritisation and evaluation in clinical trials, including a candidate vaccine…

Outbreak has alarmed experts because of how long it went undetected while spreading across a densely populated area.

WHO recommends two Ebola vaccine candidates for trials as Bundibugyo outbreak spreads in DRC and Uganda with no approved treatment yet.

Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo

The Bundibugyo virus, the strain of Ebola currently circulating, has no approved treatment or vaccine